Home / AREC.L : LSE

AI Analysis Fundamentals Video Analysis Similar

AI Analysis

How does AREC.L make money? Does AREC.L have pricing power? What's the Earnings Whisper? Will AREC.L profit more as the business scales? What is AREC.L's management track record? Is AREC.L's current price justified?

Arecor Therapeutics plc

85p +$0.00 (+0.00%)

LSE · 16 Sep 2026 08:52 UTC

Previous Close

81p

Day Range

79.5p85p

Year Range

55.27p100p

Market Cap

32.09M

AVG Volume

26.29K

Trailing/Forward PE

48.3/-

PEG ratio

-1.65

Dividend Yield

Next Earnings Date

2026-09-24

Primary Exchange

London Stock Exchange

Revenue (GBP)

AREC.L Revenue (GBP) by quarter
Period	Revenue (GBP)
25 Q4	-289K
25 Q2	2M
24 Q4	3.06M
24 Q2	2M
23 Q4	2.9M
23 Q2	1.67M
22 Q4	1.71M
22 Q2	693K
21 Q4	697.98K
21 Q2	460.02K

Net Income (GBP)

AREC.L Net Income (GBP) by quarter
Period	Net Income (GBP)
25 Q4	3.17M
25 Q2	-2.51M
24 Q4	-5.6M
24 Q2	-4.64M
23 Q4	-4.03M
23 Q2	-4.53M
22 Q4	-4.89M
22 Q2	-4.37M
21 Q4	-3.06M
21 Q2	-3.11M

Operating Income (GBP)

AREC.L Operating Income (GBP) by quarter
Period	Operating Income (GBP)
25 Q4	-1.54M
25 Q2	-3.06M
24 Q4	-2.8M
24 Q2	-7.89M
23 Q4	-3.61M
23 Q2	-5.56M
22 Q4	-6.11M
22 Q2	-5.66M
21 Q4	-4.07M
21 Q2	-3.01M

EBITDA (GBP)

AREC.L EBITDA (GBP) by quarter
Period	EBITDA (GBP)
25 Q4	-1.97M
25 Q2	-2.42M
24 Q4	-5.6M
24 Q2	-4.55M
23 Q4	-4.07M
23 Q2	-4.49M
22 Q4	-5.04M
22 Q2	-5.14M
21 Q4	-3.4M
21 Q2	-2.87M

Cash Flows (GBP)

AREC.L Cash Flows (GBP) by quarter
Period	Cash Flows (GBP)
25 Q4	-1.15M
25 Q2	-1.24M
24 Q4	-4.95M
24 Q2	-4.18M
23 Q4	-1.5M
23 Q2	-4.33M
22 Q4	-6.57M
22 Q2	-4.45M
21 Q4	-3.77M
21 Q2	-1.75M

EPS (GBP)

AREC.L EPS (GBP) by quarter
Period	EPS (GBP)
25 Q4	0.08
25 Q2	-0.07
24 Q4	-0.15
24 Q2	-0.15
23 Q4	-0.13
23 Q2	-0.15
22 Q4	-0.16
22 Q2	-0.16
21 Q4	-0.11
21 Q2	-0.11

Expenses (GBP)

AREC.L Expenses (GBP) by quarter
Period	Expenses (GBP)
25 Q4	2.26M
25 Q2	3.49M
24 Q4	2.14M
24 Q2	5.16M
23 Q4	7.74M
23 Q2	7M
22 Q4	7.81M
22 Q2	6.36M
21 Q4	4.74M
21 Q2	3.4M

Cash & Debt (GBP)

AREC.L Cash & Debt (GBP) by quarter
Period	Cash & Debt (GBP)
25 Q4	6.13M
25 Q2	1.89M
24 Q4	3.26M
24 Q2	2.54M
23 Q4	6.75M
23 Q2	8.23M
22 Q4	12.81M
22 Q2	13.72M
21 Q4	18.32M
21 Q2	22.15M

Debt ratios

AREC.L Debt ratios by quarter
Period	Debt ratios
25 Q4	0.41
25 Q2	0.1
24 Q4	0.16
24 Q2	0.12
23 Q4	0.34
23 Q2	0.45
22 Q4	0.76
22 Q2	1.01
21 Q4	1.9
21 Q2	2.94

Margins

AREC.L Margins by quarter
Period	Margins
25 Q4	-250.17%
25 Q2	16.38%
24 Q4	-21.98%
24 Q2	111.03%
23 Q4	110.37%
23 Q2	81.97%
22 Q4	50%
22 Q2	50%
21 Q4	50%
21 Q2	50%

Return on Capital

AREC.L Return on Capital by quarter
Period	Return on Capital
25 Q4	49.15%
25 Q2	-87.82%
24 Q4	-104.62%
24 Q2	-91.37%
23 Q4	-42.26%
23 Q2	-34.27%
22 Q4	-28.03%
22 Q2	-29.96%
21 Q4	-16.52%
21 Q2	-14.61%

Shares Outstanding

AREC.L Shares Outstanding by quarter
Period	Shares Outstanding
25 Q4	37.76M
25 Q2	37.76M
24 Q4	37.76M
24 Q2	30.63M
23 Q4	30.63M
23 Q2	30.62M
22 Q4	30M
22 Q2	27.84M
21 Q4	27.84M
21 Q2	27.68M

Book Value Per Share (GBP)

AREC.L Book Value Per Share (GBP) by quarter
Period	Book Value Per Share (GBP)
25 Q4	0.17
25 Q2	0.08
24 Q4	0.14
24 Q2	0.17
23 Q4	0.31
23 Q2	0.43
22 Q4	0.58
22 Q2	0.52
21 Q4	0.67
21 Q2	0.77

Total Assets (GBP)

AREC.L Total Assets (GBP) by quarter
Period	Total Assets (GBP)
25 Q4	8.1M
25 Q2	5.25M
24 Q4	8.72M
24 Q2	10.37M
23 Q4	15.38M
23 Q2	20.13M
22 Q4	21.77M
22 Q2	17.31M
21 Q4	20.92M
21 Q2	23.55M

No video analysis for this stock yet. Request one from our team.

AI Analysis

Arecor Therapeutics plc

Video analysis: AREC.L

Similar companies